Showing results (1611-1620 of 12,170) with videos related to
Sort By:
Pageof 1,217
Journal of Cardiovascular Pharmacology|September 15, 2005
Folic Acid does not limit endothelial dysfunction induced by ischemia and reperfusion: a human studySaverio Dragoni, Tommaso Gori, Giuseppe Di Stolfo, et al.Journal of Cardiovascular Pharmacology|September 15, 2005
Supplement of tetrahydrobiopterin by a gene transfer of GTP cyclohydrolase I cDNA improves vascular dysfunction in insulin-resistant ratsKazuya Shinozaki, Yoshihiko Nishio, Yuichi Yoshida, et al.Journal of Cardiovascular Pharmacology|September 15, 2005
The antithrombotic effect of melagatran in combination with clopidogrel and/or aspirin (carotid artery primary thrombosis study)Ting-Ting Hong, Jinbao Huang, Edward Driscoll, et al.Journal of Cardiovascular Pharmacology|September 15, 2005
Effect of antioxidants on atherosclerotic plaque formation in balloon-denuded and irradiated hypercholesterolemic rabbitsLaurent Leborgne, Rajbabu Pakala, Christian Dilcher, et al.Journal of Cardiovascular Pharmacology|September 15, 2005
Effect of combined treatment with an angiotensin II receptor antagonist and an HMG-CoA reductase inhibitor on atherosclerosis in genetically hyperlipidemic rabbitsMikio Kato, Toshio Sada, Makoto Mizuno, et al.Journal of Cardiovascular Pharmacology|August 24, 2005
Dissociation between improvement in left ventricular performance and functional class in patients with chronic heart failurePierre V Ennezat, Caroline A Ennezat, Pugazhendhi Vijayaraman, et al.Journal of Cardiovascular Pharmacology|August 24, 2005
The endothelium-dependent vasodilator effect of the nonpeptide Ang(1-7) mimic AVE 0991 is abolished in the aorta of mas-knockout miceVirginia S Lemos, Denise M R Silva, Thomas Walther, et al.Journal of Cardiovascular Pharmacology|August 24, 2005
Coronary vasodilator effects of endogenous cannabinoids in vasopressin-preconstricted unpaced rat isolated heartsJens A Wagner, Marco Abesser, Jan Karcher, et al.Journal of Cardiovascular Pharmacology|August 24, 2005
Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximoneSzabolcs Szilágyi, Piero Pollesello, Jouko Levijoki, et al.Journal of Cardiovascular Pharmacology|August 24, 2005
Monocyte release of tumor necrosis factor-alpha and interleukin-1beta in primary type IIa and IIb dyslipidemic patients treated with statins or fibratesBogusław Okopień, Robert Krysiak, Jan Kowalski, et al.Pageof 1,217